Myelopoietic Growth Factors After Stem Cell Transplantation: Does It Pay

This publication has 22 references indexed in Scilit:

• Impact of Pharmacy Practices on the Cost of Colony-Stimulating Factor Use in Pediatric Stem Cell Transplantation: An Institution-Based Analysis
  Journal of Pediatric Hematology/Oncology, 2001
• Prospective Randomized Trial Between Two Doses of Granulocyte Colony-Stimulating Factor After Ifosfamide, Carboplatin, and Etoposide in Children With Recurrent or Refractory Solid Tumors: A Children's Cancer Group Report
  Journal of Pediatric Hematology/Oncology, 2001
• Randomized trial showing equivalent efficacy of filgrastim 5 micrograms/kg/d and 10 micrograms/kg/d following high-dose chemotherapy and autologous bone marrow transplantation in high-risk lymphomas.
  Journal of Clinical Oncology, 1997
• Filgrastim (r-metHuG-CSF): the first 10 years
  Blood, 1996
• Placebo-controlled phase III trial of lenograstim in bone-marrow transplantation
  The Lancet, 1994
• Long-term follow-up of a phase III study of recombinant human granulocyte-macrophage colony-stimulating factor after autologous bone marrow transplantation for lymphoid malignancies
  Blood, 1993
• Recombinant Granulocyte-Macrophage Colony-Stimulating Factor after Autologous Bone Marrow Transplantation for Lymphoid Cancer
  New England Journal of Medicine, 1991
• Recombinant human granulocyte colony-stimulating factor hastens granulocyte recovery after high-dose chemotherapy and autologous bone marrow transplantation in Hodgkin's disease.
  Journal of Clinical Oncology, 1989
• GRANULOCYTE COLONY-STIMULATING FACTOR AND NEUTROPHIL RECOVERY AFTER HIGH-DOSE CHEMOTHERAPY AND AUTOLOGOUS BONE MARROW TRANSPLANTATION
  The Lancet, 1989
• Effect of Recombinant Human Granulocyte-Macrophage Colony-Stimulating Factor on Hematopoietic Reconstitution after High-Dose Chemotherapy and Autologous Bone Marrow Transplantation
  New England Journal of Medicine, 1988